Sequence Similarity Clusters for the Entities in PDB 1TJH

Entity #1 | Chains: L
anti-HIV-1 antibody 2F5 Light Chain protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 41 1085
95 % 3 41 1311 Flexibility: Low
Max RMSD: 4.4, Avg RMSD: 0.7
PDBFlex
90 % 3 41 1334
70 % 673 2395 1
50 % 1382 4857 1
40 % 1626 5475 1
30 % 1972 6818 1
Entity #2 | Chains: H
anti-HIV-1 antibody 2F5 Heavy Chain protein, length: 237 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 7 10829
95 % 3 41 1312 Flexibility: Low
Max RMSD: 1.8, Avg RMSD: 0.6
PDBFlex
90 % 3 41 1335
70 % 666 2355 2
50 % 1383 4857 1
40 % 1627 5475 1
30 % 1973 6818 1
Entity #3 | Chains: P
Envelope glycoprotein GP41 protein, length: 13 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 2XT1 2 B CAMELID VHH 9 30538
32 5UD9 1 H Fab heavy chain 9606
33 5UD9 2 L Light chain 9606
34 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
35 4P48 1 A Antibody scFv 180 9031
36 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
37 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
38 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
39 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
40 5J1S 3 C VHH domain BS-2 30538
41 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
42 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
43 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
44 5J1T 3 C VHH domain BS-2 30538
45 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
46 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
47 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
48 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
49 4XCF 1 L 4E10 Fab light chain 9606
50 4XCF 2 H 4E10 Fab heavy chain 9606
51 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
52 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
53 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
54 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
55 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
56 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
57 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
58 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
59 5X08 1 H Fab 4E10 Heavy chain 9606
60 5X08 2 L Fab 4E10 Light chain 9606
61 2X1O 1 A, B GELSOLIN NANOBODY 9844
62 4QGY 1 A, B nanobody n25, VH domain 9844
63 5C2B 1 H scFv 3B4 heavy chain 9606
64 4XAW 1 L 4E10 Fab light chain 9606
65 4XAW 2 H 4E10 Fab heavy chain 9606
66 4P49 1 A Antibody scFv B8 9031
67 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
68 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
69 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
70 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
71 5DXW 1 A PD-L1 nanobody 10090
72 5UCB 1 H Fab Heavy Chain 9606
73 5UCB 2 L Fab Light Chain 9606
74 2VXV 1 H HUMAN IGG ABT-325 9606
75 2VXV 2 L HUMAN IGG ABT-325 9606
76 4N9O 2 B Nanobody Nb484 Nb484 9844
77 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
78 4GXV 1 H, I Antibody 1F1, heavy chain 9606
79 4GXV 2 L, M Antibody 1F1, light chain 9606
80 2VXT 1 H MURINE IGG 125-2H 10090
81 2VXT 3 L MURINE IGG 125-2H 10090
82 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
83 1T2J 1 A M12-Variable Heavy domain 9606
84 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
85 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
86 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
87 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
88 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
89 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
90 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
91 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
92 5W24 1 L 5C4 Fab Light Chain 10090
93 5W24 2 H 5C4 Fab Heavy Chain 10090
94 4HPY 1 H CH59 Fab heavy chain 9606
95 4HPY 2 L CH59 Fab light chain 9606
96 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
97 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
98 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
99 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
100 4JG1 1 L Fab light chain 9606
101 4JG1 2 H Fab heavy chain 9606
102 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
103 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
104 4KML 2 B Nanobody 9844
105 5VF2 1 A scFv 2D10 10090
106 5I8C 1 A VRC34.01 Fab heavy chain 9606
107 5I8C 2 B VRC34.01 Fab light chain 9606
108 4O5L 1 L Fab F045-092 light chain 9606
109 4O5L 2 H Fab F045-092 heavy chain 9606
110 5MYX 1 A, C Fab c#24 light chain 10090
111 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
112 4Z9K 2 B VHH2(F5) antibody 30538
113 3IFL 1 L 12A11 FAB antibody light chain 10090
114 3IFL 2 H 12A11 FAB antibody heavy chain 10090
115 5WK2 1 L M116 LIGHT CHAIN 9606
116 5WK2 2 H M116 HEAVY CHAIN FD 9606
117 3PP4 1 H GA101 Fab heavy chain 10090
118 3PP4 2 L GA101 Fab light chain 10090
119 3KDM 1 A, L Immunoglobulin light chain 9606
120 3KDM 2 B, H Immunoglobulin heavy chain 9606
121 5NIV 1 A Light chain of 5D3 Fab 10090
122 5NIV 2 B Heavy chain of 5D3 Fab 10090
123 5N4J 1 L LIGHT CHAIN 9606
124 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
125 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
126 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
127 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
128 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
129 5X4G 1 A 6H8 Fab heavy chain 10090
130 5X4G 2 B 6H8 Fab light chain 10090
131 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
132 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
133 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
134 4PTU 1 A Antibody pn132p2C05, light chain 9606
135 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
136 4TPR 1 L If kappa light chain 10090
137 4TPR 2 H Fab heavy chain 10090
138 5LMW 1 A Nanobody 9844
139 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
140 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
141 3IFN 1 H 12A11 FAB antibody heavy chain 10090
142 3IFN 2 L 12A11 FAB antibody light chain 10090
143 5U3P 1 H DH511.4 Fab Heavy Chain 9606
144 5U3P 2 L DH511.4 Fab Light Chain 9606
145 5NM0 1 A, B, C, D Nb36 9844
146 4TOY 1 H 35O22 Fab Heavy chain 9606
147 4TOY 2 L 35O22 Fab Light chain 9606
148 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
149 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
150 3NPS 2 B S4 FAB HEAVY CHAIN 9606
151 3NPS 3 C S4 FAB LIGHT CHAIN 9606
152 5I4F 1 A scFv 2D10 10090
153 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
154 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
155 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
156 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
157 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
158 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
159 4XC3 1 L 4E10 Fab light chain 9606
160 4XC3 2 H 4E10 Fab heavy chain 9606
161 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
162 4PPT 1 A Engineered single domain VHH antibody 9844
163 3R0M 1 A, B Llama VHH A12 9844
164 4M5Y 1 H, I Fab 5J8 heavy chain 9606
165 4M5Y 2 L, M Fab 5J8 light chain 9606
166 4TQE 1 L If kappa light chain 10090
167 4TQE 2 H Fab heavy chain 10090
168 3ZKQ 2 D XA4813 9844
169 4I13 2 B Protein ca1697 (nanobody) 9844
170 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
171 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
172 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
173 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
174 5C2U 1 B Nanobody Nanobody 9838
175 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
176 5VSI 2 L CH1/Ckappa Fab light chain 9606
177 1XFP 1 A heavy chain antibody VHH domain 9838
178 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
179 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
180 5JXA 1 H VRC03 Heavy chain 9606
181 5JXA 2 L VRC03 Light chain 9606
182 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
183 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
184 4POY 1 A VHH-metal 9844
185 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
186 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
187 5NLW 1 A nanobody Nb36 9844
188 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
189 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
190 3NTC 1 L Fab light chain 10090
191 3NTC 2 H Fab heavy chain 10090
192 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
193 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
194 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
195 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
196 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
197 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
198 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
199 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
200 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
201 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
202 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
203 3G9A 2 B Minimizer 9838
204 4NWU 1 H APE1551 Ab Fab heavy chain 9606
205 4NWU 2 L APE1551 Ab Fab light chain 9606
206 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
207 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
208 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
209 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
210 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
211 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
212 5EWI 1 H VRC38.01 Heavy Chain 9606
213 5EWI 2 L VRC38.01 Light Chain 9606
214 5E2W 1 L AT8 LIGHT CHAIN 10090
215 5E2W 2 H AT8 HEAVY CHAIN 10090
216 5MYK 1 A Fab c#17 light chain 10090
217 5MYK 2 B Fab c#17 heavy chain 10090
218 4NZR 1 H PGT135 heavy chain Fab 9606
219 4NZR 2 L PGT135 light chain Fab 9606
220 5MYO 1 A, C Fab c#6 light chain 10090
221 5MYO 2 B, D Fab c#6 heavy chain 10090
222 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
223 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
224 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
225 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
226 5UEL 1 H 354NC102 Fab Heavy Chain 9606
227 5UEL 2 L 354NC102 Fab Light Chain 9606
228 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
229 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
230 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
231 2P43 2 B ANTIBODY CAB-RN05 9838
232 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
233 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
234 5E2V 1 L AT8 LIGHT CHAIN 10090
235 5E2V 2 H AT8 HEAVY CHAIN 10090
236 4KRN 1 A Nanobody/VHH domain EgA1 9844
237 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
238 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
239 4GFT 2 B Nanobody 9844
240 4TVS 2 a, b VHH Domain BS-1 30538
241 4W6Y 2 B Nanobody NbFedF9 9844
242 6EZW 1 B VHH antibody BCD090-M2 9844
243 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
244 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
245 5JUE 1 L light chain of UIC2 Fab 10090
246 5JUE 2 H heavy chain of UIC2 Fab 10090
247 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
248 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
249 1UAC 2 H Ig VH,anti-lysozyme 10090
250 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
251 5JR1 1 H 10E8 heavy chain 9606
252 5JR1 2 L 10E8 mature light chain 9606
253 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
254 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
255 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
256 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
257 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
258 5OB5 2 H fAb Heavy chain 9606
259 5OB5 3 L fAb Light chain 9606
260 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
261 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
262 5I66 1 A 8B6 antibody, heavy chain 10090
263 5I66 2 B 8B6 antibody, light chain 10090
264 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
265 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
266 3QQ9 1 C, L 101F LIGHT CHAIN 10090
267 3QQ9 2 D, H 101F HEAVY CHAIN 10090
268 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
269 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
270 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
271 5W6C 1 H UCA Fab heavy chain 9606
272 5W6C 2 L UCA Fab light chain 9606
273 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
274 5I1K 1 L FAB LIGHT CHAIN 9606
275 5I1K 2 H FAB HEAVY CHAIN 9606
276 3OZ9 1 L Fab NC-1 kappa light chain 10090
277 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
278 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
279 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
280 5V7U 1 L CBTAU-22.1 Fab light chain 9606
281 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
282 5UEA 1 A, H Fab Heavy Chain 9606
283 5UEA 3 B, L Fab Light Chain 9606
284 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
285 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
286 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
287 3G5Y 1 A 175 light chain 10090
288 3G5Y 2 B 175 heavy chain 10090
289 5O02 2 C Nanobody (VHH) Nano-4 30538
290 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
291 4N8C 2 L, M Light chain of monoclonal antibody 10090
292 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
293 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
294 4HGW 1 A Antibody Fab fragment, light chain 10090
295 4HGW 2 B Antibody Fab fragment, heavy chain 10090
296 1NLB 1 L antibody 19D9D6 light chain 10090
297 1NLB 2 H antibody 19D9D6 heavy chain 10090
298 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
299 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
300 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
301 3VFG 1 L 3F8 Light Chain 10090
302 3VFG 2 H 3F8 Heavy Chain 10090
303 4X7F 2 C, D Nano-25 Nanobody 30538
304 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
305 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
306 3QRG 1 L Fab light chain 9606
307 3QRG 2 H Fab heavy chain Fd fragment 9606
308 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
309 5M6A 1 A, B, C, D Bence-Jones light chain 9606
310 4LLY 2 B, D light chain Clambda 9606
311 4LGR 2 B Camelid nanobody (VHH3) 30538
312 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
313 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
314 5EZI 1 H Fab c12 heavy chain 9606
315 5EZI 2 L Fab c12 Light chain 9606
316 4K23 1 H anti-uPAR antibody, heavy chain 10090
317 4K23 2 L anti-uPAR antibody, light chain 10090
318 5J57 2 B VHH single chain antibody V5E1 30538
319 3NCJ 1 L Fab15 Mut8 light chain 9606
320 3NCJ 2 H Fab15 Mut8 heavy chain 9606
321 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
322 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
323 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
324 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
325 5W05 1 L M59 FAB LIGHT CHAIN 10090
326 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
327 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
328 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
329 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
330 5OMM 2 C Nanobody (VHH) Nano-14 30538
331 5E03 1 A mouse CTLA-4 nanobody 10090
332 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
333 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
334 4M61 1 A, C Fab A52 light chain 10090
335 4M61 2 B, D Fab A52 heavy chain 10090
336 5LZ0 1 A, B PorM nanobody 9844
337 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
338 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
339 1UM5 1 L Antibody 21H3 L chain 10090
340 1UM5 2 H Antibody 21H3 H chain 10090
341 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
342 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
343 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
344 4NWT 1 L APE1531 Ab Fab light chain 9606
345 4NWT 2 H APE1531 Ab Fab heavy chain 9606
346 3WHX 1 A mAb Fab H fragment 10090
347 3WHX 2 B mAb Fab L fragment 10090
348 3NA9 1 L Fab15 light chain 9606
349 3NA9 2 H Fab15 heavy chain 9606
350 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
351 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
352 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
353 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
354 4LRI 1 A, B MSL-109 Light Chain 9606
355 4LRI 2 C, P MSL-109 Heavy Chain 9606
356 2XXC 1 B CAMELID VHH 9 30538
357 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
358 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
359 4JN2 1 A, L anti dabigatran Fab 10090
360 4JN2 2 B, H anti dabigatran Fab 10090
361 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
362 4XBE 2 H 4E10 Fab heavy chain 9606
363 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
364 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
365 3QYC 1 A, B VH domain of IgG molecule 9606
366 4JFZ 1 L Fab light chain 9606
367 4JFZ 2 H Fab heavy chain 9606
368 3WIF 1 A mAb Fab H fragment 10090
369 3WIF 2 B mAb Fab L fragment 10090
370 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
371 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
372 3MBX 1 L X836 LIGHT CHAIN 10090
373 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
374 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
375 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
376 2XXM 2 B CAMELID VHH 9 30538
377 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
378 4HHA 1 A Fab KE5 Fab fragment KE5 9606
379 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
380 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
381 4RGO 2 H 14G8 heavy chain Fab 10090
382 4RGO 3 L 14G8 light chain Fab 10090
383 5GRY 1 A, G diabody 9606
384 5UEK 2 H Fab 12E Heavy Chain 9606
385 5UEK 3 L Fab 12E Light Chain 9606
386 3NAA 1 L Fab15 Mut5 light chain 9606
387 3NAA 2 H Fab15 Mut5 heavy chain 9606
388 1Q0X 1 L Fab 9B1, light chain 10090
389 1Q0X 2 H Fab 9B1, heavy chain 10090
390 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
391 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
392 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
393 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
394 5JDS 1 B Nanobody 9835
395 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
396 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
397 5IK3 2 B, D 1E03 Fab fragment light chain 9606
398 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
399 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
400 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
401 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
402 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
403 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
404 4WUK 1 H CH65 heavy chain 9606
405 4WUK 2 L CH65 light chain 9606
406 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
407 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
408 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
409 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
410 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
411 5JOP 1 D, L Fab 14.22 light chain 10090
412 5JOP 2 E, H Fab14.22 heavy chain 10090
413 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
414 4HPO 1 H CH58 Fab heavy chain 9606
415 4HPO 2 L CH58 Fab light chain 9606
416 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
417 5UKN 2 L DH522UCA Fab fragment light chain 9544
418 5L21 2 B VHH-C2 30538
419 5IT2 1 H heavy chain 9606
420 5IT2 2 L light chain 9606
421 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
422 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
423 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
424 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
425 5FWO 1 A NANOBODY 9844
426 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
427 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
428 5GZ0 1 A, C FM329 light chain 1383439
429 5GZ0 2 B, D FM329 heavy chain 1383439
430 3B9V 1 A, B, C, D heavy chain variable domain 9606
431 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
432 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
433 4PUB 1 H DX-2930 HEAVY CHAIN 9606
434 4PUB 2 L DX-2930 LIGHT CHAIN 9606
435 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
436 6B14 2 L Light chain of Fab BL3-6S97N 10090
437 5N88 1 A, H VH59 antibody 9606
438 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
439 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
440 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
441 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
442 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
443 5GS3 1 A, H diabody protein 9606
444 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
445 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
446 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
447 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
448 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
449 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
450 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
451 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
452 5XHG 1 A, C polypeptide(L) 562
453 5XHG 2 B, D polypeptide(H) 562
454 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
455 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
456 3UYR 1 H antibody Fab heavy chain 10090
457 3UYR 2 L antibody Fab light chain 10090
458 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
459 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
460 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
461 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
462 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
463 3OAZ 2 K, L Fab 2G12, light chain 9606
464 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
465 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
466 1ZAN 1 L Fab AD11 Light Chain 10116
467 1ZAN 2 H Fab AD11 Heavy Chain 10116
468 4N0Y 1 H IGH526 Heavy Chain 9606
469 4N0Y 2 L IGH526 Light Chain 9606
470 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
471 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
472 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
473 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
474 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
475 1RZF 1 L Fab E51 light chain 9606
476 1RZF 2 H Fab E51 heavy chain 9606
477 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
478 4KTE 2 L GE148 Light Chain Fab 9544
479 5I8O 1 H HMM5 antibody heavy chain 9606
480 5I8O 2 L HMM5 antibody light chain 9606
481 4OUO 1 A anti Bla g 1 scFv 9031
482 4JG0 1 L Fab light chain 9606
483 4JG0 2 H Fab heavy chain 9606
484 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
485 4YGV 2 B, L aDabi-Fab2a light chain 9606
486 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
487 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
488 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
489 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
490 3EO0 1 A, C GC-1008 Fab Light Chain 10090
491 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
492 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
493 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
494 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
495 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
496 4POU 2 B VHH Antibody 9844
497 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
498 4FQI 3 H antibody CR9114 heavy chain Fab 9606
499 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
500 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
501 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
502 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
503 4JHA 2 L D25 light chain 9606
504 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
505 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
506 4PTT 1 A Antibody pn132p2C05, light chain 9606
507 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
508 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
509 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
510 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
511 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
512 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
513 2P42 2 B, D ANTIBODY CAB-RN05 9838
514 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
515 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
516 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
517 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
518 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
519 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
520 4DGV 1 H HCV1 Heavy Chain Fab 9606
521 4DGV 2 L HCV1 Light Chain 9606
522 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
523 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
524 5TH2 1 A, C cetuximab Fab, light chain 10090
525 5TH2 2 B, D cetuximab Fab, heavy chain 10090
526 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
527 5I8K 1 L HHH1 Fab Light chain 9606
528 5I8K 2 H HHH1 Fab Heavy chain 9606
529 4QLR 1 A, B Llama nanobody n02 VH domain 9844
530 5J56 2 B VHH single chain antibody V1C7 30538
531 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
532 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
533 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
534 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
535 1YNL 1 L Ig gamma light chain 10090
536 1YNL 2 H Ig gamma heavy chain 10090
537 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
538 5EPM 2 B, F Antibody Fab fragment light chain 10090
539 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
540 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
541 3UMT 1 A scFv heavy chain and light chain 10090
542 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
543 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
544 4NUJ 1 A PGT152 light chain 9606
545 4NUJ 2 B PGT152 heavy chain 9606
546 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
547 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
548 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
549 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
550 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
551 3U2S 2 B, L PG9 light chain 9606
552 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
553 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
554 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
555 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
556 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
557 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
558 4NUG 1 L PGT151 light chain 9606
559 4NUG 2 H PGT151 heavy chain 9606
560 3IU4 1 H chP3 Fab heavy chain 10090
561 3IU4 2 L chP3 Fab light chain 10090
562 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
563 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
564 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
565 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
566 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
567 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
568 1P7K 1 A, L antibody light chain FAB 10090
569 1P7K 2 B, H antibody heavy chain FAB 10090
570 4NBX 2 B A20.1 VHH 9844
571 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
572 3RVV 2 C 4C1 - light chain 10090
573 3RVV 3 D 4C1 - heavy chain 10090
574 4HEP 2 G vHH17 domain 9844
575 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
576 3P0Y 2 H Fab DL11 heavy chain 9606
577 3P0Y 3 L Fab DL11 light chain 9606
578 4NPY 1 A, L germline PGT121 light chain Fab 9606
579 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
580 5IBU 1 B, L 6652 Light Chain 9606
581 5IBU 2 G, H 6652 Heavy Chain 9606
582 5VPL 2 C 4C1 - LIGHT CHAIN 10090
583 5VPL 3 D 4C1 - HEAVY CHAIN 10090
584 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
585 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
586 2YPV 2 H FAB 12C1 10090
587 2YPV 3 L FAB 12C1 10090
588 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
589 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
590 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
591 4JY5 1 L PGT122 light chain Fab 9606
592 4JY5 2 H PGT122 heavy chain Fab 9606
593 6ELE 1 A, H fAB heavy chain 9606
594 6ELE 2 B, L fAB light chain 9606
595 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
596 5IML 2 B Nanobody 9835
597 3NAC 1 L Fab15 Mut7 light chain 9606
598 3NAC 2 H Fab15 Mut7 heavy chain 9606
599 3A6C 2 H IG VH, anti-lysozyme 10090
600 2DQD 2 H Ig VH,anti-lysozyme 10090
601 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
602 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
603 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
604 1Q72 1 L Fab M82G2, Light chain 10090
605 1Q72 2 H Fab M82G2, Heavy chain 10090
606 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
607 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
608 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
609 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
610 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
611 4YHO 1 H aDabi-Fab3 heavy chain 9606
612 4YHO 2 L aDabi-Fab3 light chain 9606
613 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
614 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
615 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
616 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
617 4DGY 1 H HCV1 Heavy Chain Fab 9606
618 4DGY 2 L HCV1 Light Chain 9606
619 3A67 2 H IG VH, anti-lysozyme 10090
620 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
621 5EN2 1 A GD01 heavy chain 10090
622 5EN2 2 B GD01 light chain 10090
623 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
624 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
625 1J1X 2 H Ig VH,anti-lysozyme 10090
626 5M2J 2 D Anti-(ED-B) scFV 9606
627 3MXW 2 L 5E1 light chain 9606
628 3MXW 3 H 5E1 heavy chain 9606
629 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
630 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
631 2DQC 2 H Ig VH,anti-lysozyme 10090
632 1J1O 2 H Ig VH,anti-lysozyme 10090
633 3EO9 1 L Efalizumab Fab fragment, light chain 9606
634 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
635 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
636 4M62 2 H, I GEP2 FV heavy chain 9606
637 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
638 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
639 5IVO 1 A BC2-nanobody 30538
640 1J1P 2 H Ig VH,anti-lysozyme 10090
641 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
642 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
643 4NBZ 2 B, D A26.8 VHH 9844
644 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
645 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
646 5WUV 1 L light chain 9606
647 5WUV 2 H heavy chain 9606
648 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
649 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
650 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
651 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
652 5AYU 2 H Ig VH,anti-lysozyme 10090
653 4JM4 1 H PGT 135 Heavy Chain Fab 9606
654 4JM4 2 L PGT 135 Light Chain Fab 9606
655 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
656 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
657 3A6B 2 H IG VH, anti-lysozyme 10090
658 2DQJ 2 H Ig VH,anti-lysozyme 10090
659 5F21 2 B nanobody MU375 9844
660 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
661 6B0G 1 C 1245 Antibody, Light Chain 9606
662 6B0G 2 D 1245 Antibody, Heavy Chain 9606
663 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
664 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
665 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
666 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
667 2P44 2 B ANTIBODY CAB-RN05 9838
668 5TPP 1 L DH270.5 Fab heavy chain 9606
669 5TPP 2 H DH270.5 Fab light chain 9606
670 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
671 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
672 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
673 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
674 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
675 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
676 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
677 5TP3 1 A, B F-VHH-4 9844
678 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
679 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
680 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
681 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
682 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
683 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
684 5TL5 1 L M2177 LIGHT CHAIN 10090
685 5TL5 2 H M2177 HEAVY CHAIN 10090
686 2FX7 1 L Fab 4E10 Light Chain 9606
687 2FX7 2 H Fab 4E10 Heavy Chain 9606
688 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
689 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
690 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
691 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
692 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
693 4LHJ 2 B Camelid antibody 30538
694 3WFH 1 A mAb Fab H fragment 10090
695 3WFH 2 B mAb Fab L fragment 10090
696 4BEL 2 D, E XA4813 9844
697 5M7Q 1 A, B Nanobody NbD2 9838
698 5H8D 1 A VHH nanobody 9844
699 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
700 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
701 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
702 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
703 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
704 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
705 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
706 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
707 3DUR 2 B, D Ig-like protein 10090
708 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
709 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
710 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
711 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
712 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
713 5HI4 3 D, L CAT-2000 FAB light chain 9606
714 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
715 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
716 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
717 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
718 3RVW 2 C 4C1 - light chain 10090
719 3RVW 3 D 4C1 - heavy chain 10090
720 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
721 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
722 5XKU 2 B HNIgGA6 light chain 9606
723 5XKU 3 C HNIgGA6 heavy chain 9606
724 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
725 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
726 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
727 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
728 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
729 5HI5 3 D, L CAT-2000 light chain 9606
730 5JO5 1 A, C, E, H 10E8 gHV 9606
731 5JO5 2 B, D, F, L 10E8 gLV 9606
732 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
733 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
734 2XV6 2 B, D CAMELID VHH 9 30538
735 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
736 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
737 5CCK 2 L Antibody 3BC315 Fab light chain 9606
738 5I76 1 A, C FM318_light_chain 1383439
739 5I76 2 B, D FM318_heavy_cahin 1383439
740 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
741 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
742 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
743 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
744 5I18 1 L FAB LIGHT CHAIN 9606
745 5I18 2 H FAB HEAVY CHAIN 9606
746 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
747 4JN1 2 L anti-dabigatran Fab1, light chain 10090
748 4ZG1 1 A, B, C, D, E, F NB17 9844
749 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
750 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
751 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
752 4G5Z 2 L canakinumab antibody fragment light chain 9606
753 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
754 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
755 2OK0 2 L Fab ED10 light chain 10090
756 2OK0 3 H Fab ED10 heavy chain 10090
757 3SOB 1 L antibody light chain 9606
758 3SOB 3 H antibody heavy chain 9606
759 4I1N 2 B Protein ca1697 (nanobody) 9844
760 5AWN 1 H Heavy chain of 3BC176 Fab 9606
761 5AWN 2 L Light chain of 3BC176 Fab 9606
762 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
763 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
764 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
765 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
766 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
767 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
768 5DR5 2 L AbD09097 Fab light chain 9606
769 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
770 2IH3 1 A FAB Heavy Chain 10090
771 2IH3 2 B FAB Light Chain 10090
772 4KQ3 1 L CNTO3186 light chain Fab 9606
773 4KQ3 2 H CNTO3186 heavy chain Fab 9606
774 6F0D 1 A, B VHH antibody BCD090-M2 9844
775 4JFX 1 A, L Fab light chain 9606
776 4JFX 2 B, H Fab heavy chain 9606
777 3SGE 1 I, L Light Chain 10090
778 3SGE 2 H, J Heavy Chain 10090
779 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
780 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
781 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
782 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
783 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
784 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
785 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
786 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
787 5FHB 1 H Antibody 100 Fab heavy chain 9606
788 5FHB 2 L Antibody 100 Fab light chain 9606
789 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
790 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
791 1JGU 1 L Antibody Light Chain 10090
792 1JGU 2 H Antibody Heavy Chain 10090
793 4I77 1 H Lebrikizumab heavy chain Fab 9606
794 4I77 2 L Lebrikizumab light chain Fab 9606
795 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
796 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
797 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
798 4O4Y 2 H 2095-2 heavy chain 9986
799 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
800 5OBF 1 H fAb Heavy chain 10090
801 5OBF 2 L fAb Light chain 10090
802 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
803 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
804 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
805 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
806 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
807 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
808 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
809 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
810 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
811 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
812 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
813 4GLR 3 I, K anti-ptau light chain light chain 9031
814 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
815 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
816 4HJG 1 A Trastuzumab light chain 9606
817 4HJG 2 B Trastuzumab heavy chain 9606
818 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
819 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
820 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
821 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
822 5I30 1 L Fab PL-2 light chain 10090
823 5I30 2 H Fab PL-2 heavy chain 10090
824 4W6X 2 B Nanobody NbFedF7 9844
825 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
826 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
827 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
828 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
829 3FN0 1 L Fab Z13e1 light chain 9606
830 3FN0 2 H Fab Z13e1 heavy chain 9606
831 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
832 4YHI 2 B, L aDabi-Fab2a light chain 9606
833 4OSU 1 H SM5-1 Fab Heavy Chain 9606
834 4OSU 2 L SM5-1 Fab Light Chain 9606
835 5JA9 2 A, B Nanobody 6 9844
836 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
837 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
838 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
839 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
840 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
841 1T2Q 1 L Fab NNA7 Heavy Chain 10090
842 1T2Q 2 H Fab NNA7 Light Chain 10090
843 6ELJ 1 A, H fAB heavy chain 9606
844 6ELJ 2 B, L fAB light chain 9606
845 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
846 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
847 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
848 4MAU 1 L C2244 light chain SEE REMARK 999 10090
849 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
850 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
851 3LEX 2 B, L 11f10 Antibody Light Chain 10090
852 6B0W 1 L 1710 antibody, light chain 9606
853 6B0W 2 H 1710 antibody, heavy chain 9606
854 1OP3 1 K, L FAB 2G12, light chain light chain 9606
855 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
856 1OP9 1 A HL6 camel VHH fragment 9838
857 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
858 5VH4 2 B, L Infliximab Fab Light Chain 10090
859 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
860 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
861 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
862 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
863 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
864 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
865 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
866 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
867 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
868 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
869 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
870 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
871 4LRN 1 H GEP 1 heavy chain 9606
872 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
873 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
874 4S11 1 A GELSOLIN NANOBODY 9844
875 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
876 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
877 3S96 1 A, C 3B5H10 FAB heavy chain 10090
878 3S96 2 B, D 3B5H10 FAB light chain 10090
879 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
880 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
881 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
882 4LKX 1 A Fab fragment heavy chain 9606
883 4LKX 2 B Fab fragment light chain 9606
884 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
885 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
886 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
887 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
888 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
889 5JW5 1 A, H MEDI8852 Heavy chain 9606
890 5JW5 2 B, L MEDI8852 Light chain 9606
891 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
892 5VH3 2 B, L Infliximab Fab Light Chain 10090
893 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
894 5HDQ 2 H Fab Heavy Chain 10090
895 5HDQ 3 L Fab Light Chain 10090
896 4FQ2 1 H Fab heavy chain 9606
897 4FQ2 2 L Fab light chain 9606
898 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
899 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
900 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
901 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
902 2A77 1 L Immunoglobulin Light Chain 10090
903 2A77 2 H Immunoglobulin Heavy Chain 10090
904 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
905 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
906 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
907 3GO1 1 L Fab 268-D, light chain 9606
908 3GO1 2 H Fab 268-D, heavy chain 9606
909 4Y7M 1 A, B Hi113 protein 9844
910 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
911 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
912 3QWO 1 B, L motavizumab light chain 10090
913 3QWO 2 A, H motavizumab heavy chain 10090
914 3CVI 1 H 25-D1.16 Heavy chain 10090
915 3CVI 2 L 25-D1.16 Light chain 10090
916 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
917 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
918 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
919 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
920 5JMO 2 C, D camelid VHH fragment 9838
921 4IOI 1 A Trastuzumab light chain 9606
922 4IOI 2 B Trastuzumab heavy chain 9606
923 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
924 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
925 4OKV 1 A, C heavy chain of 8H7 mAb 10090
926 4OKV 2 B, D light chain of 8H7 mAb 10090
927 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
928 5K8A 2 B, F, H, V Heavy chain 10090
929 1JGV 1 L Antibody Light Chain 10090
930 1JGV 2 H Antibody Heavy Chain 10090
931 5VAG 2 B Light chain of antibody m826 9606
932 5VAG 3 C Heavy chain of antibody m826 9606
933 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
934 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
935 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
936 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
937 5GIR 1 A, H Heavy chain of Fab fragment 10090
938 5GIR 2 B, L Light chain of Fab fragment 10090
939 2ADF 2 H 82D6A3 IgG FAB 10090
940 2ADF 3 L 82D6A3 IgG FAB 10090